Recommend Products

Special Offer

Bulk Products

New Arrivals

Hot Sales

Hot Sales

Chemical Structure Cat. No. Product Name CAS No.
TPX-0005 Chemical Structure
BCP19778 TPX-0005 1802220-02-5
TPX-0005 is a potent ALK/ROS1/TRK inhibitor, with IC50 of 5.3 nM, 1.01 nM, 1.26 nM and 1.08 nM for SRC, WT ALK, ALK G1202R and ALK L1196M, respectively.
Cabazitaxel Chemical Structure
BCP27641 Cabazitaxel 183133-96-2
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
Temsirolimus Chemical Structure
BCP25281 Temsirolimus 162635-04-3
Temsirolimus (CCI-779, NSC 683864) is a specific mTOR inhibitor with IC50 of 1.76 μM in a cell-free assay.
Furafylline Chemical Structure
BCP20952 Furafylline 80288-49-9
Furafylline is a potent and selective inhibitor of human cytochrome P450IA2 with an IC50 of 0.07 μM.
BMS-986205 Chemical Structure
BCP20339 BMS-986205 1923833-60-6
GSK2330672 Chemical Structure
BCP17155 GSK2330672 1345982-69-5
GSK2330672 is a highly potent, nonabsorbable ASBT(apical sodium-dependent bile acid transporter) inhibitor (hASBT IC50=42 ± 3 nM) which lowers glucose in an animal model of type 2 diabetes and shows excellent developability properties for evaluating the potential therapeutic utility of a nonabsorbable ASBT inhibitor for treatment of patients with type 2 diabetes.
APR-246 Chemical Structure
BCP20294 APR-246 5291-32-7
APR-246, also known as PRIMA-1MET, is a quinuclidinone derivative that targets the Wrap53 gene with potential antineoplastic activity. p53 activator APR-246 binds to and activates transcription of the Wrap53 gene, which results in an increase in WRAP53 p53 antisense transcript levels and, potentially, an increase in native p53 activity; in turn, increased p53 activity may lead to an induction of cell cycle arrest and apoptosis in tumor cells. This agent may work synergistically with other antineoplastic agents.
Nicotinamide Riboside Chloride Chemical Structure
BCP20094 Nicotinamide Riboside Chloride 23111-00-4
Nicotinamide riboside is a pyridine-nucleoside form of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+.
Brivaracetam Chemical Structure
BCP14251 Brivaracetam 357336-20-0
Brivaracetam(UCB-34714) is a 4-substituted pyrrolidone butanamide as agent with significant antiepileptic activity; high affinity SV2A ligand and also shows an ability to inhibit Na+ channels.
NSC 133723 Chemical Structure
BCP02884 NSC 133723 19741-14-1
NSC 131463 is a dihydrofolate reductase potent inhibitor with an IC50 of 1 nM.
AZD0156 Chemical Structure
BCP18990 AZD0156 1821428-35-6
AZD0156 is an oral, potent and selective ATM kinase inhibitor, inhibiting the kinase activity of ATM and ATM-mediated signaling, preventing DNA damage checkpoint activation, and disrupting DNA damage repair, inducing tumor cell apoptosis, and leading to cell death in ATM-overexpressing tumor cells.
MK-1775 Chemical Structure
BCP01928 MK-1775 955365-80-7
MK-1775 is a potent and selective Wee1 kinase inhibitor with an IC50 of 5.2 nM.
Nicotinamide Riboside Chemical Structure
BCP06938 Nicotinamide Riboside 1341-23-7
Bleomycin Sulphate Chemical Structure
BCP01387 Bleomycin Sulphate 9041-93-4
Bleomycin sulfate is a potent DNA damaging agent, as the best-studied micronucleus (MN) inducer. Bleomycin also is a natural antibiotic, toxic to dividing cells (G2/M-phase), also proven effective in squamous cell carcinomas (SCC).
FABP4 Inhibitor Chemical Structure
BCP02448 FABP4 Inhibitor 300657-03-8
FABP4 Inhibitor is a cell-permeable biphenylazolo-oxyacetate that acts as a potent and selective inhibitor of adipocyte Fatty-Acid-Binding Protein (aFABP/aP2) by targeting its fatty acid-binding pocket (Ki = < 2 nM in a competitive binding assay using 1,8-ANS), while exhibiting much lower affinity for muscle and epidermal FABP's (Ki = 250 nM and 350 nM, respectively).
Resiquimod Chemical Structure
BCP09103 Resiquimod 144875-48-9
MCC-950 Chemical Structure
BCP15729 MCC-950 210826-40-7
MCC950(CP-456773) is a potent, selective, small-molecule inhibitor of NLRP3 with IC50 of 7.5 nM in BMDMs.
Vortioxetine Chemical Structure
BCP05996 Vortioxetine 508233-74-7
Vortioxetine (Lu AA21004) is an investigational novel antidepressant with multimodal activity that functions as a 5-HT3, 5-HT7 and 5-HT1D receptor antagonist, 5-HT1B receptor partial agonist, 5-HT1A receptor agonist and inhibitor of the 5-HT transporter in vitro.
Anlotinib Dihydrochloride Chemical Structure
BCP19682 Anlotinib Dihydrochloride 1360460-82-7
Anlotinib Dihydrochloride is a novel multi-target tyrosine kinase inhibitor that is designed to primarily inhibit VEGFR2/3, FGFR1-4, PDGFRα/β, c-Kit, and Ret.
CCT245737 Chemical Structure
BCP18991 CCT245737 1489389-18-5
CCT245737 is a potent, ATP-competitive CHK1 inhibitor with an IC50 of 30-220 nM.
12下一页共 40 条记录 1 / 2 页